These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 1958445)

  • 1. Effects of tenoxicam on renal function and the disposition of inulin and p-aminohippurate in healthy volunteers and patients with chronic renal failure.
    Freestone S; McAuslane JA; Prescott LF
    Br J Clin Pharmacol; 1991 Oct; 32(4):495-500. PubMed ID: 1958445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The comparative effects of paracetamol and indomethacin on renal function in healthy female volunteers.
    Prescott LF; Mattison P; Menzies DG; Manson LM
    Br J Clin Pharmacol; 1990 Apr; 29(4):403-12. PubMed ID: 2183866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dipyrone and diclofenac do not influence creatinine-clearance, inulin-clearance or PAH-clearance in healthy male volunteers.
    Farker K; Nassr N; Huck F; Zerle G; Rosenkranz B; Schmieder G; Hoffmann A
    Int J Clin Pharmacol Ther; 1995 Mar; 33(3):125-30. PubMed ID: 7599909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of short-term treatment with diclofenac-colestyramine on renal function and urinary prostanoid excretion in patients with type-2 diabetes.
    Farker K; Merkel U; Schweer H; Haerting J; Madani SF; Eggers R; Müller UA; Seyberth HW; Hoffmann A
    Eur J Clin Pharmacol; 2002 May; 58(2):85-91. PubMed ID: 12012138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The concentration-dependent disposition of intravenous p-aminohippurate in subjects with normal and impaired renal function.
    Prescott LF; Freestone S; McAuslane JA
    Br J Clin Pharmacol; 1993 Jan; 35(1):20-9. PubMed ID: 8448064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single- and multiple-dose pharmacokinetics, kidney tolerability and plasma protein binding of tenoxicam in renally impaired patients and healthy volunteers.
    Nilsen OG; Aasarød K; Widerøe TE; Guentert TW
    Pharmacol Toxicol; 2001 Nov; 89(5):265-72. PubMed ID: 11881981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reassessment of the single intravenous injection method with inulin for measurement of the glomerular filtration rate in man.
    Prescott LF; Freestone S; McAuslane JA
    Clin Sci (Lond); 1991 Feb; 80(2):167-76. PubMed ID: 1848170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fenofibrate increases blood creatinine, but does not change the glomerular filtration rate in patients with mild renal insufficiency].
    Hottelart C; el Esper N; Achard JM; Pruna A; Fournier A
    Nephrologie; 1999; 20(1):41-4. PubMed ID: 10081035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of the degree of renal damage on p-aminohippuric acid and inulin clearances in rats.
    Gloff CA; Benet LZ
    J Pharmacokinet Biopharm; 1989 Apr; 17(2):169-77. PubMed ID: 2795454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tenoxicam i.v. for major gynaecological surgery--effects on renal function.
    Jones RD; Endre Z; Miles W; Prankerd R; Chilvers M; Willgoss D
    Anaesth Intensive Care; 2000 Oct; 28(5):501-9. PubMed ID: 11094664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of IGF-I on renal function in patients with chronic renal failure.
    O'Shea MH; Miller SB; Hammerman MR
    Am J Physiol; 1993 May; 264(5 Pt 2):F917-22. PubMed ID: 8498545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Tenoxicam and renal function. Short-term and long-term prospective studies].
    Giovannoni JL; Ott H; de Torrenté A
    Schweiz Med Wochenschr; 1990 May; 120(21):793-7. PubMed ID: 2349462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The concentration-dependent disposition and kinetics of inulin.
    Prescott LF; McAuslane JA; Freestone S
    Eur J Clin Pharmacol; 1991; 40(6):619-24. PubMed ID: 1884745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of IGF-I on renal function in end-stage chronic renal failure.
    Miller SB; Moulton M; O'Shea M; Hammerman MR
    Kidney Int; 1994 Jul; 46(1):201-7. PubMed ID: 7933838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Apalcillin and renal function].
    Fillastre JP; Moulin B; Josse S; Frelon JH
    Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):694-8. PubMed ID: 3054749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal tolerance for ioxaglate in patients with chronic renal failure.
    Deray G; Cacoub P; Jacquiaud C; Drobinski G; Brillet G; Bunker D; Jaudon MC; Jacobs C
    Radiology; 1991 May; 179(2):395-7. PubMed ID: 2014280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study on the possible interaction between tenoxicam and furosemide.
    Hartmann D; Kleinbloesem CH; Lücker PW; Vetter G
    Arzneimittelforschung; 1987 Sep; 37(9):1072-6. PubMed ID: 3501723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal haemodynamic actions of pressor doses of lysine vasopressin in the rat.
    Lote CJ; McVicar AJ; Thewles A
    J Physiol; 1987 Oct; 391():407-18. PubMed ID: 3443952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin-induced depression of glomerular filtration rate in normal humans: role of sodium balance.
    Muther RS; Potter DM; Bennett WM
    Ann Intern Med; 1981 Mar; 94(3):317-21. PubMed ID: 7013593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tenoxicam does not alter renal function during anaesthesia in normal individuals.
    Slaven GM; Walker RJ; Zacharias M; Fawcett JP; Hodgson BF
    Aust N Z J Med; 1998 Dec; 28(6):772-6. PubMed ID: 9972405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.